Forecasting of Oxidant/Antioxidant Levels of COVID-19 Patients by Using Expert Models with Biomarkers Used in the Diagnosis/Prognosis of COVID-19

Overview

Journal Int Immunopharmacol

Specialties Allergy & Immunology
Pharmacology

Date 2021 Sep 18

PMID 34536746

Citations 20

Authors

Mehmet Tahir Huyut

Zubeyir Huyut

Affiliations

Soon will be listed here.

Abstract

Background: Early detection of oxidant-antioxidant levels and special care in severe patients are important in combating the COVID-19 epidemic. However, this process is costly and time consuming. Therefore, there is a need for faster, reliable and economical methods.

Methods: In this study, antioxidant/oxidant levels of patients were estimated by Expert-models using biomarkers, which are effective in the diagnosis/prognosis of COVID-19 disease. For this purpose, Expert-models were trained and created between the white-blood-cell-count (WBC), lymphocyte-count (LYM), C-reactive-protein (CRP), D-dimer, ferritin values of 35 patients with COVID-19 and antioxidant/oxidant parameter values of the same patients. Error criteria and R ratio were taken into account for the performance of the models. The validity of the all models was checked by the Box-Jenkis-method.

Results: Antioxidant/Oxidant levels were estimated with 95% confidence-coefficient using the values of WBC, LYM, CRP, D-dimer, ferritin of different 500 patients diagnosed with COVID-19 with the trained models. The error rate of all models was low and the coefficients of determination were sufficient. In the first data set, there was no significant difference between measured antioxidant/oxidant levels and predicted antioxidant/oxidant levels. This result showed that the models are accurate and reliable. In determining antioxidant/oxidant levels, LYM and ferritin biomarkers had the most effect on models, while WBC and CRP biomarkers had the least effect. The antioxidant/oxidant parameter estimated with the highest accuracy was Native-Thiol divided by Total-Thiol.

Conclusions: The results showed that the antioxidant/oxidant levels of infected patients can be estimated accurately and reliably with LYM, ferritin, D-dimer, WBC, CRP biomarkers in the COVID-19 outbreak.

Citing Articles

The external validity of machine learning-based prediction scores from hematological parameters of COVID-19: A study using hospital records from Brazil, Italy, and Western Europe.

Safdari A, Keshav C, Mody D, Verma K, Kaushal U, Burra V PLoS One. 2025; 20(2):e0316467.

PMID: 39903736 PMC: 11793750. DOI: 10.1371/journal.pone.0316467.

Machine learning approaches to predict the need for intensive care unit admission among Iranian COVID-19 patients based on ICD-10: A cross-sectional study.

Karimi Z, Malak J, Aghakhani A, Najafi M, Ariannejad H, Zeraati H Health Sci Rep. 2024; 7(9):e70041.

PMID: 39229475 PMC: 11369020. DOI: 10.1002/hsr2.70041.

Logistic regression analysis of the value of biomarkers, clinical symptoms, and imaging examinations in COVID-19 for SARS-CoV-2 nucleic acid detection.

Huang S, Zhang X, Ni X, Chen L, Ruan F Medicine (Baltimore). 2024; 103(19):e38186.

PMID: 38728447 PMC: 11081620. DOI: 10.1097/MD.0000000000038186.

Development of Biomarkers and Prognosis Model of Mortality Risk in Patients with COVID-19.

Zhang Z, Tang L, Guo Y, Guo X, Pan Z, Ji X J Inflamm Res. 2024; 17:2445-2457.

PMID: 38681069 PMC: 11048291. DOI: 10.2147/JIR.S449497.

Association Between Hemoglobin-Albumin-Lymphocyte-Platelet Index and Mortality in Hospitalized COVID-19 Omicron BA.2 Infected Patients.

Wu W, Lu W, Hong D, Yu X, Xiong L Infect Drug Resist. 2024; 17:1467-1476.

PMID: 38628242 PMC: 11020245. DOI: 10.2147/IDR.S451613.

References

Nelson B . Statistical methodology: V. Time series analysis using autoregressive integrated moving average (ARIMA) models. Acad Emerg Med. 1998; 5(7):739-44. DOI: 10.1111/j.1553-2712.1998.tb02493.x. View

Kunnumakkara A, Rana V, Parama D, Banik K, Girisa S, Henamayee S . COVID-19, cytokines, inflammation, and spices: How are they related?. Life Sci. 2021; 284:119201. PMC: 7884924. DOI: 10.1016/j.lfs.2021.119201. View

Gulcin I . Antioxidant activity of food constituents: an overview. Arch Toxicol. 2011; 86(3):345-91. DOI: 10.1007/s00204-011-0774-2. View

Tahamtan A, Ardebili A . Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020; 20(5):453-454. PMC: 7189409. DOI: 10.1080/14737159.2020.1757437. View

Mousavi S, Rad S, Rostami T, Rostami M, Mousavi S, Mirhoseini S . Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020; 25(1):383-388. DOI: 10.1080/16078454.2020.1833435. View

Zheng Y, Zhang Y, Chi H, Chen S, Peng M, Luo L . The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study. Clin Chem Lab Med. 2020; 58(7):1106-1115. DOI: 10.1515/cclm-2020-0377. View

Donyavi T, Bokharaei-Salim F, Baghi H, Khanaliha K, Alaei Janat-Makan M, Karimi B . Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int Immunopharmacol. 2021; 97:107641. PMC: 8023203. DOI: 10.1016/j.intimp.2021.107641. View

Ayinde K, Lukman A, Rauf R, Alabi O, Okon C, Ayinde O . Modeling Nigerian Covid-19 cases: A comparative analysis of models and estimators. Chaos Solitons Fractals. 2020; 138:109911. PMC: 7282783. DOI: 10.1016/j.chaos.2020.109911. View

Han H, Yang L, Liu R, Liu F, Wu K, Li J . Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 58(7):1116-1120. DOI: 10.1515/cclm-2020-0188. View

10.

Petropoulos F, Makridakis S . Forecasting the novel coronavirus COVID-19. PLoS One. 2020; 15(3):e0231236. PMC: 7108716. DOI: 10.1371/journal.pone.0231236. View

11.

Petrou P . Failed Attempts to Reduce Inappropriate Laboratory Utilization in an Emergency Department Setting in Cyprus: Lessons Learned. J Emerg Med. 2015; 50(3):510-7. DOI: 10.1016/j.jemermed.2015.07.025. View

12.

Sekeroglu M, Huyut Z, Him A . The susceptibility of erythrocytes to oxidation during storage of blood: effects of melatonin and propofol. Clin Biochem. 2012; 45(4-5):315-9. DOI: 10.1016/j.clinbiochem.2011.12.021. View

13.

Roosa K, Lee Y, Luo R, Kirpich A, Rothenberg R, Hyman J . Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020. Infect Dis Model. 2020; 5:256-263. PMC: 7033348. DOI: 10.1016/j.idm.2020.02.002. View

14.

Mansur J, Tajer C, Mariani J, Inserra F, Ferder L, Manucha W . Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection. Clin Investig Arterioscler. 2020; 32(6):267-277. PMC: 7256522. DOI: 10.1016/j.arteri.2020.05.003. View

15.

Arshad M, Khan U, Sadiq A, Khalid W, Hussain M, Yasmeen A . Coronavirus disease (COVID-19) and immunity booster green foods: A mini review. Food Sci Nutr. 2020; 8(8):3971-3976. PMC: 7300634. DOI: 10.1002/fsn3.1719. View

16.

Cetin Cakmak K, Gulcin I . Anticholinergic and antioxidant activities of usnic acid-an activity-structure insight. Toxicol Rep. 2019; 6:1273-1280. PMC: 6889762. DOI: 10.1016/j.toxrep.2019.11.003. View

17.

Katris C . A time series-based statistical approach for outbreak spread forecasting: Application of COVID-19 in Greece. Expert Syst Appl. 2020; 166:114077. PMC: 7531284. DOI: 10.1016/j.eswa.2020.114077. View

18.

Anastassopoulou C, Russo L, Tsakris A, Siettos C . Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS One. 2020; 15(3):e0230405. PMC: 7108749. DOI: 10.1371/journal.pone.0230405. View

19.

Mertoglu C, Huyut M, Arslan Y, Ceylan Y, Coban T . How do routine laboratory tests change in coronavirus disease 2019?. Scand J Clin Lab Invest. 2020; 81(1):24-33. DOI: 10.1080/00365513.2020.1855470. View

20.

Teymouri M, Mollazadeh S, Mortazavi H, Ghale-Noie Z, Keyvani V, Aghababaei F . Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathol Res Pract. 2021; 221:153443. PMC: 8045416. DOI: 10.1016/j.prp.2021.153443. View